-transparent.png){kind=logo}
The toxicity of chenodeoxycholic acid was studied in squirrel monkeys of both sexes. The drug was orally administered to five groups of 26 animals each at a daily dose of 0, 10, 20, 40, and 80 mg per kg, respectively, for a maximum of 52 weeks. No clinical symptoms that could suggest drug toxicity were observed. All laboratory studies, including liver function tests, were within normal limits. The proportion of lithocholic acid in biliary acids remained unchanged, whereas that of chenodeoxycholic acid was dose-dependently increased. No histopathological changes considered to be attributable to drug administration were observed.
Related Publications
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
August 1975,
Gastroenterology,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
September 1985,
Gastroenterology,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
January 1975,
Medecine & chirurgie digestives,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
June 1968,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
June 1975,
Surgery,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
November 1969,
Journal of the National Cancer Institute,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
January 1976,
Gastroenterology,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
January 1975,
Journal of steroid biochemistry,
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
December 1974,
Lancet (London, England),
H Suzuki, and
T Yoshida, and
H Miki, and
T Sado, and
K Hashimoto
February 1979,
Gastroenterologie clinique et biologique,
